As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
With its new digital therapeutics platform, Mind Cure is positioning itself as an emerging leader in the psychedelic drug industry.
Mind Cure has acquired Epiphany360, a digital therapeutics platform for the treatment of mental health conditions.
Mind Cure adds an expert in neuroscience and nutrition to its Advisory Board.
After a series of significant corporate appointments, Mind Cure is poised to advance its operations.
Mr. Bier is a communications and strategy expert who has played a key role in building brands
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now